These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S. Arthritis Rheum; 2011 Apr; 63(4):1076-85. PubMed ID: 21452327 [Abstract] [Full Text] [Related]
3. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. Huang Y, Qiao F, Atkinson C, Holers VM, Tomlinson S. J Immunol; 2008 Dec 01; 181(11):8068-76. PubMed ID: 19017999 [Abstract] [Full Text] [Related]
4. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential. Michelfelder S, Fischer F, Wäldin A, Hörle KV, Pohl M, Parsons J, Reski R, Decker EL, Zipfel PF, Skerka C, Häffner K. J Am Soc Nephrol; 2018 Apr 01; 29(4):1141-1153. PubMed ID: 29335241 [Abstract] [Full Text] [Related]
5. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F, Tang PH, Kunchithapautham K, Gilkeson GS, Tomlinson S. Invest Ophthalmol Vis Sci; 2009 Jul 01; 50(7):3056-64. PubMed ID: 19264882 [Abstract] [Full Text] [Related]
6. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy. Yang Y, Denton H, Davies OR, Smith-Jackson K, Kerr H, Herbert AP, Barlow PN, Pickering MC, Marchbank KJ. J Am Soc Nephrol; 2018 Jun 01; 29(6):1649-1661. PubMed ID: 29588430 [Abstract] [Full Text] [Related]
7. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy. Vernon KA, Ruseva MM, Cook HT, Botto M, Malik TH, Pickering MC. J Am Soc Nephrol; 2016 May 01; 27(5):1334-42. PubMed ID: 26374608 [Abstract] [Full Text] [Related]
8. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy. Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Schubert S, Noris M, Tomasoni S, Remuzzi G, Zoja C, Benigni A. Mol Immunol; 2024 Apr 01; 168():10-16. PubMed ID: 38368725 [Abstract] [Full Text] [Related]
9. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models. Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V. Mol Immunol; 2019 Jan 01; 105():150-164. PubMed ID: 30513451 [Abstract] [Full Text] [Related]
10. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily. Wang X, Van Lookeren Campagne M, Katschke KJ, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC. J Am Soc Nephrol; 2018 Aug 01; 29(8):2053-2059. PubMed ID: 29895552 [Abstract] [Full Text] [Related]
11. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation. Zanchi C, Locatelli M, Corna D, Cerullo D, Fishilevich E, Desai D, Rottoli D, Donadelli R, Noris M, Zoja C, Remuzzi G, Benigni A. Mol Immunol; 2023 Sep 01; 161():25-32. PubMed ID: 37481826 [Abstract] [Full Text] [Related]
12. Characterization of C3 in C3 glomerulopathy. Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH. Nephrol Dial Transplant; 2017 Mar 01; 32(3):459-465. PubMed ID: 27507892 [Abstract] [Full Text] [Related]
13. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Ruseva MM, Takahashi M, Fujita T, Pickering MC. Clin Exp Immunol; 2014 Apr 01; 176(1):84-92. PubMed ID: 24279761 [Abstract] [Full Text] [Related]
14. Proof of concept of a new plasma complement Factor H from waste plasma fraction. Mori F, Pascali G, Berra S, Lazzarotti A, Panetta D, Rocchiccioli S, Ceccherini E, Norelli F, Morlando A, Donadelli R, Clivio A, Farina C, Noris M, Salvadori PA, Remuzzi G. Front Immunol; 2024 Apr 01; 15():1334151. PubMed ID: 38919628 [Abstract] [Full Text] [Related]
15. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases]. He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J. Zhonghua Er Ke Za Zhi; 2012 Dec 01; 50(12):939-43. PubMed ID: 23324154 [Abstract] [Full Text] [Related]